|
China began the first human trials of a new AIDS vaccine in Southwest China's Guangxi Zhuang Autonomous Region on Saturday (Mar. 12th).
A man, 20, was the first to volunteer to receive the AIDS vaccine in Nanning, the capital, Saturday, followed by seven others, four of them women. They all signed waivers and received physical checkups.
Some 49 volunteers aged between 18 and 50 will receive the tests in three phases, the first lasting 14 months. The second phase will test the immune nature and safety of the vaccine.
The State Food and Drug Administration approved the first clinical phase research of the new AIDS vaccine Nov. 25 last year.
The government estimates that China, with a population of 1.3 billion, has 840,000 people infected with HIV.
The AIDS virus has infected more than 43 million people worldwide and killed 25 million. The incurable virus spreads through sexual contact, blood products and mothers' milk but can be controlled to some degree with cocktails of drugs called highly active antiretroviral therapy.
There have been about 35 AIDS vaccine trials on humans throughout the world, most of which are still in the first phase.
Editor: Catherine
This site contains material from other media for content enrichment purpose only.
The Southcn.com website do not endorse such content and do not bear the joint responsibility of their copyright infringement.
The views expressed in written material posted to the bulletin boards of Southcn.com are those of the authors and/or publishers. The Southcn.com website does not endorse information products posted by organizations and individuals here. The originators of these information products are solely responsible for their content.
For copyright infringement issues, you shall contact Southcn.com within thirty (30) days. Email: falv@southcn.com
|
